On the eve of the Falsified Medicines Directive (FMD) the chief executives of the RPS and the GPhC have published a joint statement on the impending legislation due to come into force tomorrow. The legal requirements of the safety features Delegated Regulation under the FMD will be in force from tomorrow (9 February 2019) onwards. The chief executives of the GPhC and RPS met earlier this week to discuss professional concerns around FMD implementation.
Duncan Rudkin, Chief Executive of the General Pharmaceutical Council, said:
“We recognise that not all pharmacies will be meeting the legal obligations of FMD straight away. We intend to take a pragmatic and proportionate approach to the implementation of the new safety features. When inspecting a pharmacy, our inspectors would consider all of the relevant evidence, including whether the pharmacy had a clear plan in place to meet all of the requirements of FMD, before deciding whether or not the relevant standard had been met.”
Paul Bennett, Chief Executive of the RPS, said:
“We welcome the pragmatic approach taken by the GPhC in relation to FMD, which we hope will provide some assurance to our members in pharmacies that are still working towards meeting all of the requirements relating to FMD. The RPS has produced to support members and we are also here to answer any queries that members have.”